Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023

Table of Contents

1 INTRODUCTION 14

1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKET COVERED 15
1.4 YEARS CONSIDERED FOR THE STUDY 15
1.5 CURRENCY 16
1.6 LIMITATIONS 16
1.7 STAKEHOLDERS 16

2 RESEARCH METHODOLOGY 17

2.1 RESEARCH DATA 17
2.1.1 SECONDARY DATA 18
2.1.1.1 Key data from secondary sources 18
2.1.2 PRIMARY DATA 18
2.1.2.1 Key data from primary sources 19
2.2 MARKET SIZE ESTIMATION 20
2.2.1 BOTTOM-UP APPROACH 20
2.2.2 TOP-DOWN APPROACH 21
2.3 DATA TRIANGULATION METHODOLOGY 22
2.4 ASSUMPTIONS FOR THE STUDY 23

3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 27

4.1 HEMOSTATS: MARKET OVERVIEW 27
4.2 ASIA PACIFIC: HEMOSTATS MARKET, BY FORMULATION (2018) 28
4.3 HEMOSTATS MARKET, BY REGION (2018) 29
4.4 GEOGRAPHICAL SNAPSHOT OF THE HEMOSTATS MARKET 30

5 MARKET OVERVIEW 31

5.1 INTRODUCTION 31
5.2 MARKET DYNAMICS 31
5.3 DRIVERS 32
5.3.1 INCREASING NUMBER OF SURGICAL PROCEDURES 32
5.3.2 GROWING NUMBER OF REGULATORY APPROVALS 32
5.3.3 INCREASING INCIDENCE OF SPORTS-RELATED INJURIES AND SPINAL AILMENTS 33
5.3.4 RISING FOCUS ON EFFECTIVE BLOOD LOSS MANAGEMENT IN PATIENTS DURING SURGERIES 33
5.4 MARKET OPPORTUNITIES 33
5.4.1 GROWTH IN THE NUMBER OF HOSPITALS & SURGICAL CENTERS 33
5.4.2 EMERGING MARKETS 34
5.5 MARKET RESTRAINTS 34
5.5.1 PRODUCT RECALLS 34
5.5.2 HIGHLY CONSOLIDATED MARKET 35
5.6 MARKET CHALLENGES 35
5.6.1 DEARTH OF SKILLED PERSONNEL 35
5.6.2 HIGH COST OF HEMOSTATS 36

6 HEMOSTATS MARKET, BY PRODUCT 37

6.1 INTRODUCTION 38
6.2 THROMBIN-BASED HEMOSTATS 39
6.3 OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS 40
6.4 COMBINATION HEMOSTATS 41
6.5 GELATIN-BASED HEMOSTATS 42
6.6 COLLAGEN-BASED HEMOSTATS 43

7 HEMOSTATS MARKET, BY FORMULATION 45

7.1 INTRODUCTION 46
7.2 MATRIX & GEL HEMOSTATS 47
7.3 SHEET & PAD HEMOSTATS 48
7.4 SPONGE HEMOSTATS 49
7.5 POWDER HEMOSTATS 50

8 HEMOSTATS MARKET, BY APPLICATION 51

8.1 INTRODUCTION 52
8.2 ORTHOPEDIC SURGERY 53
8.3 GENERAL SURGERY 54
8.4 NEUROLOGICAL SURGERY 55
8.5 CARDIOVASCULAR SURGERY 56
8.6 RECONSTRUCTIVE SURGERY 57
8.7 GYNECOLOGICAL SURGERY 58
8.8 OTHER SURGERIES 59
 

9 HEMOSTATS MARKET, BY REGION 61

9.1 INTRODUCTION 62
9.2 NORTH AMERICA 63
9.2.1 US 67
9.2.2 CANADA 68
9.3 EUROPE 70
9.3.1 GERMANY 73
9.3.2 UK 74
9.3.3 FRANCE 75
9.3.4 ITALY 77
9.3.5 SPAIN 78
9.3.6 RUSSIA 79
9.3.7 SWITZERLAND 81
9.3.8 BELGIUM 82
9.3.9 REST OF EUROPE 83
9.4 ASIA PACIFIC 84
9.4.1 CHINA 87
9.4.2 JAPAN 88
9.4.3 INDIA 90
9.4.4 AUSTRALIA 91
9.4.5 SINGAPORE 92
9.4.6 NEW ZEALAND 94
9.4.7 SOUTH KOREA 95
9.4.8 INDONESIA 96
9.4.9 MALAYSIA 98
9.4.10 REST OF ASIA PACIFIC 99
9.5 LATIN AMERICA 100
9.5.1 BRAZIL 102
9.5.2 MEXICO 104
9.5.3 REST OF LATIN AMERICA 105
9.6 MIDDLE EAST AND AFRICA 107

10 COMPETITIVE LANDSCAPE 110

10.1 OVERVIEW 110
10.2 MARKET SHARE ANALYSIS 111
10.3 COMPETITIVE SCENARIO 112
10.3.1 PRODUCT LAUNCHES AND APPROVALS 112
10.3.2 ACQUISITIONS 113
10.3.3 AGREEMENTS 113
10.3.4 EXPANSIONS 113
 

11 COMPANY PROFILES 114

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 C. R. BARD 114
11.2 B.BRAUN 116
11.3 BAXTER 118
11.4 INTEGRA LIFESCIENCES 120
11.5 MARINE POLYMER TECHNOLOGIES 122
11.6 PFIZER 123
11.7 GELITA MEDICAL GMBH 125
11.8 Z-MEDICA, LLC 126
11.9 ETHICON (SUBSIDIARY OF JOHNSON & JOHNSON) 128
11.10 TELEFLEX INCORPORATED 130

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX 132

LIST OF TABLES

TABLE 1 HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 38
TABLE 2 HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 39
TABLE 3 THROMBIN-BASED HEMOSTATS MARKET, BY REGION, 2016–2023 (USD MILLION) 39
TABLE 4 THROMBIN-BASED HEMOSTATS MARKET, BY REGION,
2016–2023 (THOUSAND UNITS) 40
TABLE 5 OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS MARKET,
BY REGION, 2016–2023 (USD MILLION) 40
TABLE 6 OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS MARKET,
BY REGION, 2016–2023 (THOUSAND UNITS) 41
TABLE 7 COMBINATION HEMOSTATS MARKET, BY REGION, 2016–2023 (USD MILLION) 41
TABLE 8 COMBINATION HEMOSTATS MARKET, BY REGION, 2016–2023 (THOUSAND UNITS) 42
TABLE 9 GELATIN-BASED HEMOSTATS MARKET, BY REGION, 2016–2023 (USD MILLION) 42
TABLE 10 GELATIN-BASED HEMOSTATS MARKET, BY REGION,
2016–2023 (THOUSAND UNITS) 43
TABLE 11 COLLAGEN-BASED HEMOSTATS MARKET, BY REGION, 2016–2023 (USD MILLION) 43
TABLE 12 COLLAGEN-BASED HEMOSTATS MARKET, BY REGION,
2016–2023 (THOUSAND UNITS) 44
TABLE 13 HEMOSTATS MARKET, BY FORMULATION, 2016–2023 (USD MILLION) 46
TABLE 14 MATRIX & GEL HEMOSTATS MARKET, BY REGION, 2016–2023 (USD MILLION) 47
TABLE 15 SHEET & PAD HEMOSTATS MARKET, BY REGION, 2016–2023 (USD MILLION) 48
TABLE 16 SPONGE HEMOSTATS MARKET, BY REGION, 2016–2023 (USD MILLION) 49
TABLE 17 POWDER HEMOSTATS MARKET, BY REGION, 2016–2023 (USD MILLION) 50
TABLE 18 HEMOSTATS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 52
TABLE 19 HEMOSTATS MARKET FOR ORTHOPEDIC SURGERY, BY REGION,
2016–2023 (USD MILLION) 53
TABLE 20 HEMOSTATS MARKET FOR GENERAL SURGERY, BY REGION,
2016–2023 (USD MILLION) 54
TABLE 21 HEMOSTATS MARKET FOR NEUROLOGICAL SURGERY,
BY REGION, 2016–2023 (USD MILLION) 55
TABLE 22 HEMOSTATS MARKET FOR CARDIOVASCULAR SURGERY,
BY REGION, 2016–2023 (USD MILLION) 56
TABLE 23 HEMOSTATS MARKET FOR RECONSTRUCTIVE SURGERY,
BY REGION, 2016–2023 (USD MILLION) 57
TABLE 24 COUNTRIES WITH THE HIGHEST C-SECTION RATE (2015) 58
TABLE 25 HEMOSTATS MARKET FOR GYNECOLOGICAL SURGERY,
BY REGION, 2016–2023 (USD MILLION) 59
TABLE 26 HEMOSTATS MARKET FOR OTHER SURGERIES, BY REGION,
2016–2023 (USD MILLION) 60
TABLE 27 HEMOSTATS MARKET, BY REGION, 2016–2023 (USD MILLION) 63
TABLE 28 NORTH AMERICA: HEMOSTATS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 65
TABLE 29 NORTH AMERICA: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 65
TABLE 30 NORTH AMERICA: HEMOSTATS MARKET, BY PRODUCT,
2016-2023 (THOUSAND UNITS) 65
TABLE 31 NORTH AMERICA: HEMOSTATS MARKET, BY FORMULATION,
2016–2023 (USD MILLION) 66
TABLE 32 NORTH AMERICA: HEMOSTATS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 66
TABLE 33 US: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 67
TABLE 34 US: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 68
TABLE 35 CANADA: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 69
TABLE 36 CANADA: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 69
TABLE 37 EUROPE: HEMOSTATS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 70
TABLE 38 EUROPE: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 71
TABLE 39 EUROPE: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 71
TABLE 40 EUROPE: HEMOSTATS MARKET, BY FORMULATION, 2016–2023 (USD MILLION) 72
TABLE 41 EUROPE: HEMOSTATS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 72
TABLE 42 GERMANY: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 73
TABLE 43 GERMANY: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 ( THOUSAND UNITS) 73
TABLE 44 UK: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 74
TABLE 45 UK: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 75
TABLE 46 FRANCE: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 76
TABLE 47 FRANCE: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 76
TABLE 48 ITALY: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 77
TABLE 49 ITALY: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 77
TABLE 50 SPAIN: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 78
TABLE 51 SPAIN: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 79
TABLE 52 RUSSIA: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 80
TABLE 53 RUSSIA: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 80
TABLE 54 SWITZERLAND: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 81
TABLE 55 SWITZERLAND: HEMOSTATS MARKET, BY PRODUCT,
2016–2023 (THOUSAND UNITS) 81
TABLE 56 BELGIUM: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 82
TABLE 57 BELGIUM: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 82
TABLE 58 ROE: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 83
TABLE 59 ROE: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 83
TABLE 60 ASIA PACIFIC: HEMOSTATS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 84
TABLE 61 ASIA PACIFIC: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 85
TABLE 62 ASIA PACIFIC: HEMOSTATS MARKET, BY PRODUCT,
2016–2023 (THOUSAND UNITS) 85
TABLE 63 ASIA PACIFIC: HEMOSTATS MARKET, BY FORMULATION,
2016–2023 (USD MILLION) 86
TABLE 64 ASIA PACIFIC: HEMOSTATS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 86
TABLE 65 CHINA: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 87
TABLE 66 CHINA: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 88
TABLE 67 JAPAN: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 89
TABLE 68 JAPAN: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 89
TABLE 69 INDIA: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 90
TABLE 70 INDIA: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 91
TABLE 71 AUSTRALIA: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 91
TABLE 72 AUSTRALIA: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 92
TABLE 73 SINGAPORE: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 93
TABLE 74 SINGAPORE: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 93
TABLE 75 NEW ZEALAND: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 94
TABLE 76 NEW ZEALAND: HEMOSTATS MARKET, BY PRODUCT,
2016–2023 (THOUSAND UNITS) 94
TABLE 77 SOUTH KOREA: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 95
TABLE 78 SOUTH KOREA: HEMOSTATS MARKET, BY PRODUCT,
2016–2023 (THOUSAND UNITS) 96
TABLE 79 INDONESIA: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 97
TABLE 80 INDONESIA: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 97
TABLE 81 MALAYSIA: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 98
TABLE 82 MALAYSIA: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 98
TABLE 83 ROAPAC: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 99
TABLE 84 ROAPAC: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 99
TABLE 85 LATIN AMERICA: HEMOSTATS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 100
TABLE 86 LATIN AMERICA: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 100
TABLE 87 LATIN AMERICA: HEMOSTATS MARKET, BY PRODUCT,
2016–2023 (THOUSAND UNITS) 101
TABLE 88 LATIN AMERICA: HEMOSTATS MARKET, BY FORMULATION,
2016–2023 (USD MILLION) 101
TABLE 89 LATIN AMERICA: HEMOSTATS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 102
TABLE 90 BRAZIL: KEY MACROINDICATORS FOR THE HEMOSTATS MARKET 102
TABLE 91 BRAZIL: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 103
TABLE 92 BRAZIL: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 103
TABLE 93 MEXICO: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 104
TABLE 94 MEXICO: HEMOSTATS MARKET, BY PRODUCT, 2016–2023 (THOUSAND UNITS) 105
TABLE 95 REST OF LATIN AMERICA: HEMOSTATS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 105
TABLE 96 REST OF LATIN AMERICA: HEMOSTATS MARKET, BY PRODUCT,
2016–2023 (THOUSAND UNITS) 106
TABLE 97 MIDDLE EAST AND AFRICA: HEMOSTATS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 107
TABLE 98 MIDDLE EAST AND AFRICA: HEMOSTATS MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 108
TABLE 99 MIDDLE EAST AND AFRICA: HEMOSTATS MARKET, BY PRODUCT,
2016–2023 (THOUSAND UNITS) 108
TABLE 100 MIDDLE EAST AND AFRICA: HEMOSTATS MARKET, BY FORMULATION,
2016–2023 (USD MILLION) 109
TABLE 101 MIDDLE EAST AND AFRICA: HEMOSTATS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 109
 

LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY 17
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS 19
FIGURE 3 BOTTOM-UP APPROACH 20
FIGURE 4 TOP-DOWN APPROACH 21
FIGURE 5 DATA TRIANGULATION 22
FIGURE 6 HEMOSTATS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION) 24
FIGURE 7 HEMOSTATS MARKET, BY FORMULATION, 2018 VS. 2023 (USD MILLION) 25
FIGURE 8 HEMOSTATS MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION) 25
FIGURE 9 HEMOSTATS MARKET, BY REGION, 2018 VS. 2023 (USD MILLION) 26
FIGURE 10 INCREASING NUMBER OF SURGICAL PROCEDURES IS EXPECTED
TO DRIVE MARKET GROWTH 27
FIGURE 11 MATRIX AND GEL HEMOSTATS ARE EXPECTED TO COMMAND
THE LARGEST MARKET SHARE IN 2018 28
FIGURE 12 NORTH AMERICA IS EXPECTED TO HOLD THE LARGEST SHARE
OF THE HEMOSTATS MARKET IN 2018 29
FIGURE 13 INDIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 30
FIGURE 14 HEMOSTATS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 31
FIGURE 15 COMBINATION HEMOSTATS TO WITNESS THE HIGHEST GROWTH IN THE HEMOSTATS MARKET DURING THE FORECAST PERIOD 38
FIGURE 16 SPONGE HEMOSTATS TO WITNESS THE HIGHEST GROWTH DURING
THE FORECAST PERIOD 46
FIGURE 17 RECONSTRUCTIVE SURGERY TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 52
FIGURE 18 NORTH AMERICA TO DOMINATE THE GLOBAL HEMOSTATS MARKET IN 2018 62
FIGURE 19 NORTH AMERICA: HEMOSTATS MARKET SNAPSHOT 64
FIGURE 20 KEY DEVELOPMENTS OF MAJOR PLAYERS FROM 2015 TO 2018 110
FIGURE 21 HEMOSTATS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 111
FIGURE 22 C. R. BARD: COMPANY SNAPSHOT (2016) 114
FIGURE 23 B. BRAUN: COMPANY SNAPSHOT (2017) 116
FIGURE 24 BAXTER: COMPANY SNAPSHOT (2017) 118
FIGURE 25 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2017) 120
FIGURE 26 PFIZER: COMPANY SNAPSHOT (2017) 123
FIGURE 27 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2017) 128
FIGURE 28 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2017) 130

当レポートのプレスリリースは発行されておりません。